{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:35Z","timestamp":1781636075937,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pathological CGG expansions in the\n                    <jats:italic>FMR1<\/jats:italic>\n                    gene, encompassing premutations (55\u2013200 repeats) and full range mutations (&gt;\u2009200 repeats), cause a spectrum of complex and incurable disorders. Premutation carriers (PMC), particularly men, face the risk of developing fragile X-associated tremor\/ataxia syndrome (FXTAS). Other conditions associated with premutations in\n                    <jats:italic>FMR1<\/jats:italic>\n                    include both Fragile X-associated primary ovarian insufficiency (FXPOI), and Fragile X-associated neuropsychiatric disorders (FXAND). Hyperintensities in the middle cerebellar peduncle (MCP), known as the MCP sign, have been considered a radiological hallmark for FXTAS.\n                    <jats:italic>FMR1<\/jats:italic>\n                    -related disorders have not been characterized in Scandinavia. Here, we delineate the clinical spectrum of\n                    <jats:italic>FMR1<\/jats:italic>\n                    related disorders among PMC emphasizing neuroimaging abnormalities and assess the correlation between CGG repeat size and clinical parameters as well as neuroimaging abnormalities at a tertiary center in Sweden. In total 33 PMC were evaluated (19 women and 14 men) of which 21 received a\n                    <jats:italic>FMR1<\/jats:italic>\n                    related disorder (64%). As expected, penetrance for a\n                    <jats:italic>FMR1<\/jats:italic>\n                    related disorder was higher among men (11\/14 [79%]) than in women (12\/19, [63%]). We also found that hyperintensities in the splenium of corpus callosum (CCS sign) were more prevalent than the MCP sign, and volumetric analyses revealed atrophy in the basal ganglia, cerebellar grey and white matter among FXTAS patients. CGG expansion size correlated with motor scores but not with age of onset. Our findings indicate a high prevalence of\n                    <jats:italic>FMR1-<\/jats:italic>\n                    related disorders in this PMC cohort in which the CCS sign is more common than the MCP sign. Larger cohort studies are necessary to assess atrophy of the basal ganglia and its clinical correlations among\n                    <jats:italic>FMR1<\/jats:italic>\n                    PMC.\n                  <\/jats:p>","DOI":"10.1007\/s12311-026-01968-6","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:33:33Z","timestamp":1770968013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Heterogeneity in a Scandinavian FMR1 Premutation Carrier Cohort and Basal Ganglia Atrophy in FXTAS"],"prefix":"10.1007","volume":"25","author":[{"given":"Sofia","family":"Berglund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farouk","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Laffita-Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Malmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt-Marie","family":"Anderlid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Granberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Sj\u00f6str\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Paucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"18","key":"1968_CR1","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.3390\/cells12182330","volume":"12","author":"F Tassone","year":"2023","unstructured":"Tassone F, Protic D, Allen EG et al. Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation. Cells. 2023;12(18):2330. https:\/\/doi.org\/10.3390\/cells12182330","journal-title":"Cells"},{"issue":"1","key":"1968_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/wnl.57.1.127","volume":"57","author":"RJ Hagerman","year":"2001","unstructured":"Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57(1):127\u201330. https:\/\/doi.org\/10.1212\/wnl.57.1.127.","journal-title":"Neurology"},{"issue":"4","key":"1968_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1086\/374321","volume":"72","author":"S Jacquemont","year":"2003","unstructured":"Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72(4):869\u201378. https:\/\/doi.org\/10.1086\/374321.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1968_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","volume":"12","author":"RJ Hagerman","year":"2016","unstructured":"Hagerman RJ, Hagerman P. Fragile X-associated tremor\/ataxia syndrome - features, mechanisms and management. Nat Rev Neurol. 2016;12(7):403\u201312.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1968_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archneur.60.1.117","volume":"60","author":"MA Leehey","year":"2003","unstructured":"Leehey MA, Munhoz RP, Lang AE, et al. The fragile X premutation presenting as essential tremor. Arch Neurol. 2003;60(1):117\u201321 https:\/\/doi.org\/10.1001\/archneur.60.1.117. PMID: 12533098.","journal-title":"Arch Neurol"},{"issue":"11","key":"1968_CR6","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1212\/01.wnl.0000145709.61117.08","volume":"63","author":"P Pugliese","year":"2004","unstructured":"Pugliese P, Annesi G, Cutuli N, et al. The fragile X premutation presenting as postprandial hypotension. Neurology. 2004;63(11):2188\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000145709.61117.08.","journal-title":"Neurology"},{"issue":"1","key":"1968_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1037\/0894-4105.22.1.48","volume":"22","author":"J Grigsby","year":"2008","unstructured":"Grigsby J, Brega AG, Engle K et al. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor\/ataxia syndrome. Neuropsychology. 2008;22(1):48\u201360 https:\/\/doi.org\/10.1037\/0894-4105.22.1.48. PMID: 18211155.","journal-title":"Neuropsychology"},{"issue":"2","key":"1968_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10048-010-0270-5","volume":"12","author":"JL Juncos","year":"2011","unstructured":"Juncos JL, Lazarus JT, Graves-Allen E, et al. New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS). Neurogenetics. 2011;12(2):123\u201335. https:\/\/doi.org\/10.1007\/s10048-010-0270-5.","journal-title":"Neurogenetics"},{"key":"1968_CR9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","volume":"79","author":"E Apartis","year":"2012","unstructured":"Apartis E, Blancher A, Meissner WG, et al. New insights and the need for revised diagnostic criteria. Neurology. 2012;79:1898\u2013907. https:\/\/doi.org\/10.1212\/WNL.0b013e318271f7ff.","journal-title":"Neurology"},{"issue":"5","key":"1968_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1601-183X.2012.00779.x","volume":"11","author":"F Tassone","year":"2012","unstructured":"Tassone F, Greco CM, Hunsaker MR, et al. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav. 2012;11(5):577\u201385. https:\/\/doi.org\/10.1111\/j.1601-183X.2012.00779.x.","journal-title":"Genes Brain Behav"},{"issue":"4","key":"1968_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ajmg.b.30482","volume":"144B","author":"F Tassone","year":"2007","unstructured":"Tassone F, Adams J, Berry-Kravis EM, et al. CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor\/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet. 2007;144B(4):566\u20139. https:\/\/doi.org\/10.1002\/ajmg.b.30482.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"16 Pt 2","key":"1968_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/01.wnl.0000281692.98200.f5","volume":"70","author":"MA Leehey","year":"2008","unstructured":"Leehey MA, Berry-Kravis E, Goetz CG, et al. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008;70(16 Pt 2):1397\u2013402. https:\/\/doi.org\/10.1212\/01.wnl.0000281692.98200.f5.","journal-title":"Neurology"},{"issue":"5","key":"1968_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1399-0004.2005.00425.x","volume":"67","author":"DZ Loesch","year":"2005","unstructured":"Loesch DZ, Churchyard A, Brotchie P, et al. Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond. Clin Genet. 2005;67(5):412\u20137. https:\/\/doi.org\/10.1111\/j.1399-0004.2005.00425.x.","journal-title":"Clin Genet"},{"issue":"8","key":"1968_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","volume":"146A","author":"SM Coffey","year":"2008","unstructured":"Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008;146A(8):1009\u201316. https:\/\/doi.org\/10.1002\/ajmg.a.32060.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1968_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/01.wnl.0000269781.10417.7b","volume":"69","author":"JS Adams","year":"2007","unstructured":"Adams JS, Adams PE, Nguyen D, et al. Volumetric brain changes in females with fragile X-associated tremor\/ataxia syndrome (FXTAS). Neurology. 2007;69(9):851\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000269781.10417.7b.","journal-title":"Neurology"},{"issue":"1","key":"1968_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-013-1138-1","volume":"126","author":"P Hagerman","year":"2013","unstructured":"Hagerman P. Fragile X-associated tremor\/ataxia syndrome (FXTAS): pathology and mechanisms. Acta Neuropathol. 2013;126(1):1\u201319. https:\/\/doi.org\/10.1007\/s00401-013-1138-1.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"1968_CR17","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/mdc3.13084","volume":"7","author":"A Schneider","year":"2020","unstructured":"Schneider A, Summers S, Tassone F, et al. Women with fragile X-associated Tremor\/Ataxia syndrome. Mov Disord Clin Pract. 2020;7(8):910\u20139. https:\/\/doi.org\/10.1002\/mdc3.13084.","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"1968_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00415-014-7557-7","volume":"262","author":"M Renaud","year":"2015","unstructured":"Renaud M, Perriard J, Coudray S, et al. Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice. J Neurol. 2015;262(2):435\u201342. https:\/\/doi.org\/10.1007\/s00415-014-7557-7.","journal-title":"J Neurol"},{"issue":"3","key":"1968_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/mdc3.12449","volume":"4","author":"DA Hall","year":"2016","unstructured":"Hall DA, Hermanson M, Dunn E, et al. The corpus callosum splenium sign in fragile X-Associated tremor ataxia syndrome. Mov Disord Clin Pract. 2016;4(3):383\u20138. https:\/\/doi.org\/10.1002\/mdc3.12449.","journal-title":"Mov Disord Clin Pract"},{"issue":"1","key":"1968_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/humrep\/dev280","volume":"31","author":"RA Buijsen","year":"2016","unstructured":"Buijsen RA, Visser JA, Kramer P, et al. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency. Hum Reprod. 2016;31(1):158\u201368. https:\/\/doi.org\/10.1093\/humrep\/dev280.","journal-title":"Hum Reprod"},{"issue":"2\u20133","key":"1968_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ajmg.1320380221","volume":"38","author":"A Cronister","year":"1991","unstructured":"Cronister A, Schreiner R, Wittenberger M, et al. Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am J Med Genet. 1991;38(2\u20133):269\u201374. https:\/\/doi.org\/10.1002\/ajmg.1320380221.","journal-title":"Am J Med Genet"},{"issue":"6","key":"1968_CR22","first-page":"525","volume":"55","author":"G Mainini","year":"2003","unstructured":"Mainini G, Festa B, Messalli EM, Torella M, Ragucci A. Premature ovarian failure. Clinical evaluation of 32 cases. Minerva Ginecol. 2003;55(6):525\u20139.","journal-title":"Minerva Ginecol"},{"issue":"10","key":"1968_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/molehr\/gaaa057","volume":"26","author":"R Rosario","year":"2020","unstructured":"Rosario R, Anderson R. The molecular mechanisms that underlie fragile X-associated premature ovarian insufficiency: is it RNA or protein based? Mol Hum Reprod. 2020;26(10):727\u201337. https:\/\/doi.org\/10.1093\/molehr\/gaaa057.","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"1968_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B","volume":"83","author":"DJ Allingham-Hawkins","year":"1999","unstructured":"Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in fragile X study\u2013preliminary data. Am J Med Genet. 1999;83(4):322\u20135.","journal-title":"Am J Med Genet"},{"issue":"3","key":"1968_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","volume":"87","author":"MD Wittenberger","year":"2007","unstructured":"Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87(3):456\u201365. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.09.004.","journal-title":"Fertil Steril"},{"issue":"5","key":"1968_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00125817-200109000-00006","volume":"3","author":"DC Crawford","year":"2001","unstructured":"Crawford DC, Acu\u00f1a JM, Sherman SL. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med. 2001;3(5):359\u201371. https:\/\/doi.org\/10.1097\/00125817-200109000-00006.","journal-title":"Genet Med"},{"issue":"1","key":"1968_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/GIM.0b013e3181fa9fad","volume":"13","author":"FM Hantash","year":"2011","unstructured":"Hantash FM, Goos DM, Crossley B, et al. FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor\/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the united States. Genet Med. 2011;13(1):39\u201345. https:\/\/doi.org\/10.1097\/GIM.0b013e3181fa9fad.","journal-title":"Genet Med"},{"key":"1968_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fnagi.2014.00264","volume":"6","author":"O Voevodskaya","year":"2014","unstructured":"Voevodskaya O, Simmons A, Nordenskj\u00f6ld R, et al. Alzheimer\u2019s disease neuroimaging Initiative. The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:264. https:\/\/doi.org\/10.3389\/fnagi.2014.00264.","journal-title":"Front Aging Neurosci"},{"key":"1968_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fgene.2018.00317","volume":"9","author":"M Paucar","year":"2018","unstructured":"Paucar M, Nennesmo I, Svenningsson P. Pathological study of a FMR1 premutation carrier with progressive supranuclear palsy. Front Genet. 2018;9:317. https:\/\/doi.org\/10.3389\/fgene.2018.00317.","journal-title":"Front Genet"},{"issue":"9","key":"1968_CR30","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/mds.25473","volume":"28","author":"JY Wang","year":"2013","unstructured":"Wang JY, Hagerman RJ, Rivera SM. A multimodal imaging analysis of subcortical Gray matter in fragile X premutation carriers. Mov Disord. 2013;28(9):1278\u201384. https:\/\/doi.org\/10.1002\/mds.25473.","journal-title":"Mov Disord"},{"key":"1968_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2019.09.009","volume":"86","author":"JY Wang","year":"2020","unstructured":"Wang JY, Hessl D, Tassone F, Kim K, Hagerman RJ, Rivera SM. Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles. Neurobiol Aging. 2020;86:27\u201338. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.09.009.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1968_CR32","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.291.4.460","volume":"291","author":"S Jacquemont","year":"2004","unstructured":"Jacquemont S, Hagerman RJ, Leehey MA, et al. Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population. JAMA. 2004;291(4):460\u20139. https:\/\/doi.org\/10.1001\/jama.291.4.460.","journal-title":"JAMA"},{"issue":"4","key":"1968_CR33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/mds.27314","volume":"33","author":"R Shickman","year":"2018","unstructured":"Shickman R, Famula J, Tassone F, et al. Age- and CGG repeat-related slowing of manual movement in fragile X carriers: A prodrome of fragile X-associated tremor ataxia syndrome? Mov Disord. 2018;33(4):628\u201336. https:\/\/doi.org\/10.1002\/mds.27314.","journal-title":"Mov Disord"},{"issue":"2","key":"1968_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1176\/appi.neuropsych.21110282","volume":"35","author":"J Flavell","year":"2023","unstructured":"Flavell J, Franklin C, Nestor PJ. A systematic review of fragile X-Associated neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 2023;35(2):110\u201320. https:\/\/doi.org\/10.1176\/appi.neuropsych.21110282.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1968_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fpsyt.2018.00564","volume":"9","author":"RJ Hagerman","year":"2018","unstructured":"Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A. Fragile X-Associated neuropsychiatric disorders (FXAND). Front Psychiatry. 2018;9:564. https:\/\/doi.org\/10.3389\/fpsyt.2018.00564.","journal-title":"Front Psychiatry"},{"issue":"12","key":"1968_CR36","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.3390\/genes13122399","volume":"13","author":"R Aishworiya","year":"2022","unstructured":"Aishworiya R, Protic D, Tang SJ, Schneider A, Tassone F, Hagerman R. Fragile X-Associated neuropsychiatric disorders (FXAND) in young fragile X premutation carriers. Genes (Basel). 2022;13(12):2399. https:\/\/doi.org\/10.3390\/genes13122399. PMID: 36553666; PMCID: PMC9778214.","journal-title":"Genes (Basel)"},{"key":"1968_CR37","doi-asserted-by":"publisher","first-page":"591666","DOI":"10.3389\/fnagi.2020.591666","volume":"12","author":"J Lin","year":"2020","unstructured":"Lin J, Xu X, Hou Y, Yang J, Shang H. Voxel-Based Meta-Analysis of Gray matter abnormalities in multiple system atrophy. Front Aging Neurosci. 2020;12:591666. https:\/\/doi.org\/10.3389\/fnagi.2020.591666.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"1968_CR38","doi-asserted-by":"publisher","first-page":"e25366","DOI":"10.1002\/jnr.25366","volume":"102","author":"X Wang","year":"2024","unstructured":"Wang X, Li Y, Li B, Shang H, Yang J. Gray matter alterations in huntington\u2019s disease: A meta-analysis of VBM neuroimaging studies. J Neurosci Res. 2024;102(7):e25366. https:\/\/doi.org\/10.1002\/jnr.25366.","journal-title":"J Neurosci Res"},{"key":"1968_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.parkreldis.2018.01.009","volume":"49","author":"J Liu","year":"2018","unstructured":"Liu J, Heinsen H, Grinberg LT, Alho E, Amaro E Jr, Pasqualucci CA, R\u00fcb U, den Dunnen W, Arzberger T, Schmitz C, Kiessling M, Bader B, Danek A. Subcortical neurodegeneration in chorea: similarities and differences between chorea-acanthocytosis and huntington\u2019s disease. Parkinsonism Relat Disord. 2018;49:54\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.01.009.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-01968-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-026-01968-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-026-01968-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:13:03Z","timestamp":1781633583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-026-01968-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1007\/s12311-026-01968-6","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from both the was approved by the Swedish Ethical Review Authority (EPN dnr 2016\/2538-32). Written informed consent was obtained from all participants or their next-of-kin. All authors confirm that they have read the journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statements"}},{"value":"The study was approved by the Swedish Ethical Authority (EPN Dnr 2016\/2023-31-2) and all participats provided a written consent form upon study inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}